Matthew Kulke, MD
Zoltan Kohn Professor of Medicine
Boston University School of Medicine
Dept of Medicine
Hematology & Medical Oncology

MD, University of California, San Francisco
MMS/MMSc, Harvard Medical School

Matthew Kulke, MD, is Chief of the Section of Hematology/Oncology in the Department of Medicine at Boston Medical Center and Zoltan Kohn Professor of Medicine at Boston University School of Medicine. In addition, he serves as Deputy Director of the BU-BMC Cancer Center and Medical Director of the Clinical Cancer Center at BMC.

Kulke is currently the Director of the Program in Neuroendocrine and Carcinoid Tumors at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School. A leader in the research and treatment of neuroendocrine tumors, he has received numerous awards for his accomplishments as a clinical investigator and provider of compassionate care to patients.

He has led national and international clinical trials to identify new therapeutic and diagnostic approaches to neuroendocrine tumors and gastrointestinal malignancies. In addition, he has published more than 100 peer-reviewed articles about neuroendocrine tumors.

Kulke received his undergraduate degree from Princeton University, his MD from University of California, San Francisco School of Medicine and a master’s degree in medical science from Harvard Medical School.

He completed his residency at Brigham and Women’s Hospital in Internal Medicine and a fellowhip in medical oncology at Dana-Farber Cancer Institute.

Kulke received the George Canellos Award for Clinical Investigation and the Ruth Brufsky Award for Pancreatic Cancer Research. He currently serves on the advisory board for the European Neuroendocrine Tumor Society, the executive committee of the North American Neuroendocrine Tumor Society, and chairs the Neuroendocrine Tumor Task force for the National Cancer Institute.

Section Chief
Boston Medical Center
Hematology & Medical Oncology

Deputy Director
BU-BMC Cancer Center

Medical Director
Boston Medical Center
Clinical Cancer Center

2017 Neuroendocrine Tumor Research Foundation: Lauren Erb Award for Contributions to Neuroendocrine Tumor Research
2011 Dana-Farber Cancer Institute: Kenneth E Schwarz Center Compassionate Care Giver Award
2010 Dana-Farber Cancer Institute: Lee Nadler Extra Mile Award
2009 University of Pittsburgh School of Medicine: Ruth Brufsky Award for Excellence in Clinical Research on Pancreatic Cancer Research
2008 Dana-Farber Cancer Institute: Kenneth E Schwarz Center Compassionate Care Giver Award
2003 Dana-Farber Cancer Institute: George Canellos Award for Contributions to Clinical Research
1999-2001 Dana-Farber Cancer Institute: Discovery Fellowship
1998-1999 American Society of Clinical Oncology: Young Investigator Award
1992 UC San Francisco School of Medicine: Thesis Honors Award
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Fazio N, Martini JF, Croitoru AE, Schenker M, Li S, Rosbrook B, Fernandez K, Tomasek J, Thiis-Evensen E, Kulke M, Raymond E. Pharmacogenomic analyses of sunitinib in patients with pancreatic neuroendocrine tumors. Future Oncol. 2019 May 14. PMID: 31084373.
  2. Anthony LB, Kulke MH, Caplin ME, Bergsland E, Öberg K, Pavel M, Hörsch D, Warner RRP, O'Dorisio TM, Dillon JS, Lapuerta P, Kassler-Taub K, Jiang W. Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome. Oncologist. 2019 Jan 16. PMID: 30651397.
  3. Dasari A, Bergsland EK, Benson AB, Cai B, Huynh L, Totev T, Shea J, Duh MS, Neary MP, Dagohoy CG, Shih BE, Maurer VE, Chan J, Kulke MH. Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review Study. Oncologist. 2019 Jan 04. PMID: 30610008.
  4. Kulke MH, Benson AB, Dasari A, Huynh L, Cai B, Totev T, Roesner N, Duh MS, Neary MP, Maurer VE, Shih BE, Dagohoy CG, Chan J, Bergsland EK. Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review Study. Oncologist. 2019 Jan 03. PMID: 30606883.
  5. Yao JC, Garg A, Chen D, Capdevila J, Engstrom P, Pommier R, Van Cutsem E, Singh S, Fazio N, He W, Riester M, Patel P, Voi M, Morrissey M, Pavel ME, Kulke MH. Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials. Endocr Relat Cancer. 2019 Jan 01. PMID: 30667365.
  6. Cella D, Beaumont JL, Hudgens S, Marteau F, Feuilly M, Houchard A, Lapuerta P, Ramage J, Pavel M, Hörsch D, Kulke MH. Relationship Between Symptoms and Health-related Quality-of-life Benefits in Patients With Carcinoid Syndrome: Post Hoc Analyses From TELESTAR. Clin Ther. 2018 Dec; 40(12):2006-2020.e2. PMID: 30477789.
  7. da Silva A, Bowden M, Zhang S, Masugi Y, Thorner AR, Herbert ZT, Zhou CW, Brais L, Chan JA, Hodi FS, Rodig S, Ogino S, Kulke MH. Characterization of the Neuroendocrine Tumor Immune Microenvironment. Pancreas. 2018 10; 47(9):1123-1129. PMID: 30153220.
  8. Baudin E, Hayes AR, Scoazec JY, Filosso PL, Lim E, Kaltsas G, Frilling A, Chen J, Kos-Kudla B, Gorbunova V, Wiedenmann B, Nieveen van Dijkum E, Cwikla JB, Falkerby J, Valle JW, Kulke MH, Caplin ME. Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms. Neuroendocrinology. 2019; 108(1):7-17. PMID: 30248673.
  9. Fisher MD, Pulgar S, Kulke MH, Mirakhur B, Miller PJ, Walker MS, Schwartzberg LS. Treatment Outcomes in Patients with Metastatic Neuroendocrine Tumors: a Retrospective Analysis of a Community Oncology Database. J Gastrointest Cancer. 2018 Aug 18. PMID: 30121904; DOI: 10.1007/s12029-018-0160-x;.
  10. Abbott A, Sakellis CG, Andersen E, Kuzuhara Y, Gilbert L, Boyle K, Kulke MH, Chan JA, Jacene HA, Van den Abbeele AD. Guidance on 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy from the Experience of a Single Nuclear Medicine Division. J Nucl Med Technol. 2018 Sep; 46(3):237-244. PMID: 30076245.
Showing 10 of 196 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 196 publications over 22 distinct years, with a maximum of 24 publications in 2017

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Gastrointestinal Oncology
Neuroendocrine Tumors
Novel Therapeutics
Contact for Mentoring:

820 Harrison Ave
Boston MA 02118
Google Map

Kulke's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department